Replacing what was lost: A novel cell therapy for type I diabetes mellitus
People eat more the night before exercise, study finds
1 April 2021Malawi starts vaccination drive with AstraZeneca from COVAX
1 April 2021Replacing what was lost: A novel cell therapy for type I diabetes mellitus
Type I diabetes mellitus (T1D) is an autoimmune disorder leading to permanent loss of insulin-producing beta-cells in the pancreas. In a new study, researchers from the University of Tokyo developed a novel device for the long-term transplantation of iPSC-derived human pancreatic beta-cells.
